In the face of the delta variant taking hold in the U.S., pandemic-driven demand for packaged foods could be sticking around for longer than had… Read More »Continued Demand For Packaged Food Amid Delta Could Make This Stock A Sweet Deal – Literally.
The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.
COVID case numbers are surging again thanks the Delta variant, and concerns that this will result in more lockdowns and travel restrictions may be part of the reason for the recent pullback in oil and gas prices.
“Cancer treatments have remained a hotbed for biotech companies.”
The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.
“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.
New stocks to watch in 2021.
“When it comes to investing in biotech penny stocks, there are some ways to dramatically increase your chances of success and to give yourself a good chance of becoming a millionaire or even a multimillionaire in the process.”
“New therapies derived from psychedelic compounds…are offering hope, not to mention a slew of opportunities for forward-thinking investors.”
“All three picks can be volatile but very tradable and should be considered as long term holds with expectations for growth, positive clinical data or M&A.”